Clinical trial
Midazolam Drug-Drug Interaction Study With Lurasidone HCl
NCT01082263 is registered in ClinicalTrials.gov with Sumitomo Pharma America, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Midazolam Drug-Drug Interaction Study With Lurasidone HCl
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- November 30, 2008
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schizophrenia patients